Breviscapus breviscapus injection

This product is a sterilized aqueous solution made by extracting phenolic components from Erigeron breviscapus. It mainly contains total caffeic acid esters and baicalin (C21H18O12). Excipient: sodium chloride.

This product is a brown clear liquid.

1. Intravenous injection. 20-40 ml at a time, 1-2 times a day, diluted with 250-500 ml of 0.9% sodium chloride injection and slowly dripped. 2. Acupoint injection. 0.5-1.0 ml per acupoint, 6-10 ml in total for multiple acupoints. 3. Intramuscular injection. 4 ml at a time, 2-3 times a day.

In a large number of clinical applications, only a very small number of patients experience symptoms such as palpitations, fever, chills, itchy skin, flushing, dizziness, headache and low blood pressure. If the above conditions occur, please stop the medication immediately and treat the symptoms, and the symptoms will disappear.

1. Patients who are allergic to this product or have a history of severe adverse reactions are prohibited from using this product. 2. Patients who are allergic to preparations containing breviscapine or have a history of severe adverse reactions are prohibited from using this product. 3. Patients who are allergic to breviscapine preparations or have a history of severe adverse reactions are prohibited from using this product. 4. Patients who are allergic to baicalin or caffeic acid esters or have a history of severe adverse reactions are prohibited from using this product. 5. Patients who are allergic to breviscapine are prohibited from using this product. 6. Patients in the acute stage of cerebral hemorrhage are prohibited from using this product. 7. Patients with active bleeding (such as gastrointestinal bleeding, cerebral hemorrhage) are prohibited from using this product. 8. Patients during menstruation are prohibited from using this product. 9. Neonates and infants are prohibited from using this product. 10. Pregnant women are prohibited from using this product.

Precautions for children: Forbidden for newborns, infants and young children. Precautions for pregnancy and lactation: Forbidden for pregnant women

There is no information on the interaction of this product with other drugs.

seal.

10 ml per bottle

36 months.

Yunnan Biovalley Pharmaceutical Co., Ltd.

• Founded in:

  1999-06-13

• Address:

  No. 1, Kangjian Road, Yunnan Mile Industrial Park, Fucheng Subdistrict Office, Mile City, Honghe Hani and Yi Autonomous Prefecture, Yunnan Province

• Tax NO.:

  915301007134092367

• Registered Funds:

  124.00007 million yuan

• Website:

  Log in to view

• Email:

  Log in to view